Tianzheng Hong Kong Accountants Limited
Overseas registration of Mainland Individuals control
Cricket Square, Hutchins Drive P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of Business
Room 301-303, 3 / F, Wing Tak Commercial Centre, 177-183 Wing Lok Street, Sheung Wan, Hong Kong
Hong Kong motherboard
Qianhai Health Holdings Co., Ltd. is an investment holding company mainly engaged in purchasing and wholesale American ginseng products. The company and its subsidiaries operate through four major divisions. The planting ginseng branch is engaged in purchasing and selling the cultivated American ginseng. Wild ginseng branch is engaged in purchasing and selling American wild ginseng. Mountain ginseng wine branch is engaged in the production and sale of wild ginseng wine. Its wine products include wild Shanxi ginseng cognac wine and wild ginseng liquor. Other divisions are engaged in buying and selling other products, including Cordyceps sinensis, dried bird's nest, seafood and skin care products.
Qianhai Health Holdings Limited (formerly known as Hengfa Ginseng Holdings Limited) was incorporated as an exempted limited company in the Cayman Islands under Chapter 22 of the companies Law of the Cayman Islands (Law No. 33 of 1961, as consolidated and amended) and was officially listed on the main Board of the Stock Exchange of Hong Kong under the stock code 0911 on 27 June 2014.
The core business of Qianhai Health Holdings Limited (the "Company") and its subsidiaries (collectively referred to as "Qianhai Health" or the "Group") is the procurement and wholesale of American ginseng (PanaxquinquefoliusL.,), a perennial herb of the Araliaceae family, including cultivated ginseng and wild ginseng.
The company has been established for 30 years, has been deeply supported by customers, and has accumulated a wealth of experience in the industry. With valuable past experience, as early as the early 1990s, the Group regularly appointed senior commissioners to purchase goods from the United States and Canada, adhering to the rigorous attitude of material selection, coupled with rich knowledge and experience, the Group's business developed steadily and became the leading supplier of American ginseng in the industry.
Hong Kong is regarded as the world's leading port for receiving and transporting American ginseng. About 90% of Canadian American ginseng is exported to Hong Kong, and the Group is the largest first-class American ginseng wholesaler in Hong Kong. As a leading enterprise in the market, the Group has strong bargaining power with customers, growers and suppliers.
In 2017, the Group established Zhejiang Huizun Investment Management Co., Ltd., a wholly owned subsidiary in China. " Zhejiang Huizun is currently jointly developing Lin'an Liankou Hot Spring Villa and a medical and physical examination center with a total construction area of 70,000 square meters. The Group's vision for long-term development is through the construction, acquisition and management of general hospitals. The general hospital aims to integrate the specialties of medical treatment, rehabilitation and health care. Let the group set up the main industrial platform in Hangzhou, so that the concept of large health industry model can be fully implemented, and strive to occupy an important position in the health care and health care industry in Hangzhou.